Success Metrics

Active Trials
4(100%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Active, not recruiting2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting250%
recruiting250%

Recent Activity

4 active trials
Showing 4 of 4
recruitingnot_applicable

Enhancing Heart Allograft Function With the OCS Heart System Trial

NCT07145515
recruiting

US National OCS Heart Perfusion (OHP) Registry

NCT05915299
active_not_recruiting

OCS DCD Heart + CAP Continued Follow-Up

NCT05741723
active_not_recruiting

OCS Heart EXPAND + CAP Continued Follow-Up

NCT05096299

Clinical Trials (4)

Showing 4 of 4 trials
NCT07145515Not Applicable

Enhancing Heart Allograft Function With the OCS Heart System Trial

Recruiting
NCT05915299

US National OCS Heart Perfusion (OHP) Registry

Recruiting
NCT05741723

OCS DCD Heart + CAP Continued Follow-Up

Active Not Recruiting
NCT05096299

OCS Heart EXPAND + CAP Continued Follow-Up

Active Not Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4